An Open Label Study to Evaluate the Pharmacodynamic Effects, Efficacy, Safety and Tolerability of E2027 in Subjects with Dementia With Lewy Bodies or Parkinson's Disease Dementia With or Without Amyloid Copathology

Grants and Contracts Details

StatusFinished
Effective start/end date4/28/211/11/23

Funding

  • Eisai Incorporated: $93,586.00